Quantel Medical awarded tender for ophthalmic laser equipment from India department of defense

  • 03/30/2016
Download PDF

Quantel Medical awarded tender for ophthalmic laser equipment from India department of defense

  • 03/30/2016
Download PDF

Quantel Medical awarded tender for ophthalmic laser equipment from India department of defense

  • 03/30/2016
Download PDF

Quantel Medical (Quantel), a global ophthalmic medical device company dedicated to developing leading technologies to improve the diagnosis and treatment of ocular diseases, announced it has been awarded a €3 million competitive tender for ophthalmic laser equipment.

Under the terms of a supply agreement signed by the Directorate General of Armed Forces Medical Services of the Indian Ministry of Defense, Quantel Medical will provide 61 photocoagulator lasers (532nm Supra with Suprascan) for use in 53 military hospitals across India. The 532nm Supra with Suprascan is a diverse and versatile laser platform capable of delivering a number of Multispot and MicroPulse patterns.

Diabetes is extremely prevalent in India, affecting more than 62 million individuals, or about 7% of the adult population. It is well known that uncontrolled diabetes can be a precursor for the development of vision-related complications, including diabetic retinopathy and diabetic macular edema, both of which are also very common in India. One study suggested that as many as 20% of individuals with diabetes in India are affected by diabetic retinopathy.

This agreement will put an extremely powerful treatment option in the hands of physicians who treat patients with diabetic eye disease, and it is a platform that can be adapted to use for other applications as well. Laser treatment of diabetes is in many cases as effective as medical treatment, and it is demonstrated to be much more cost effective.

Jean-Marc Gendre, CEO of Quantel Medical

The information collected through this form is recorded and transmitted to the relevant LUMIBIRD MEDICAL departments and enables us to send you any reply to a request via the contact form. The legal basis for the processing is consent. The data collected are kept for 3 years in digital format and are only transmitted to LUMIBIRD MEDICAL’s internal departments as well as to our distributors and subsidiaries. You have a right to access, rectify, contest, limit the processing of and erase data. For more information on the use of your data and your rights resulting from the amended French Data Protection Act and the GDPR, please consult our data protection policy or contact our Data Protection Officer at rgpd@lumibirdmedical.com.
For more informations on how Quantel Medical uses your data, please see our Terms and conditions.